₹40.14
+₹1.17 (+3.00%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹1,002 Cr
P/E
40.14
ROE
15.03%
ROCE
12.76%
About Sudarshan Pharma Industries Ltd
Sudarshan Pharma Industries is engaged in manufacturing having plant for API and doing job work manufacturing in Pharmaceuticals Items and traders in Chemicals and Solvents in India.
Founded
2008
CEO
Hemal V Mehta
Employees
60
HQ
Mumbai, Maharashtra
About Sudarshan Pharma Industries Ltd
Sudarshan Pharma Industries is engaged in manufacturing having plant for API and doing job work manufacturing in Pharmaceuticals Items and traders in Chemicals and Solvents in India.
Founded:2008
CEO:Hemal V Mehta
Employees:60
HQ:Mumbai, Maharashtra
Finished Products
1Sale of goods
₹961.49Cr2Sale of Services
₹6.58CrRaw Materials
1Purchase of Stock in Trade
₹916.18Cr2Cost of materials Consumed
₹8.82CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹43
52W Low
₹19
Volume808.00K
Avg VolumeN/A
Beta0.69
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
40.14x
Valuation
P/B Ratio
5.88x
Valuation
EPS
₹1.00
Valuation
Dividend Yield
0.00%
Valuation
ROE
15.03%
Profitability
ROCE
12.76%
Profitability
Revenue by Segment
Contribution & growth by business line
Jobwork manufacturing in PharmeceutRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
1.84x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
3.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.